$ABBV · AbbVie Inc.

AbbVie Inc. filed a Form 4 with the SEC on October 2, 2026, reporting a change in beneficial ownership for Edward J. Rapp, a director of the company. The filing shows that on September 30, 2026, Mr. Rapp acquired 129 stock equivalent units at a price of $261.59 per unit. These units were credited to a stock equivalent unit account under a director’s grantor trust, representing director fees that are generally distributed over a period equal to the director’s years of board service, beginning at the later of age 65 or retirement from the board.

The stock equivalent units earn the same return as if the fees were invested directly in AbbVie common stock. After the reported transaction, Mr. Rapp beneficially owned 29,568 stock equivalent units, with the balance including units acquired through a dividend reinvestment feature. The filing reflects routine compensation-related activity for an AbbVie director and does not indicate an open-market purchase or sale of common stock.